Literature DB >> 4202261

Candida albicans septicaemia during first half of pregnancy successfully treated with 5-fluorocytosine.

J Schönebeck, E Segerbrand.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4202261      PMCID: PMC1587393          DOI: 10.1136/bmj.4.5888.337

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  7 in total

1.  Pathology of Candida infection of the umbilical cord.

Authors:  K Aterman
Journal:  Am J Clin Pathol       Date:  1968-06       Impact factor: 2.493

2.  Intra-uterine infection by Candida.

Authors:  E Lopez; K Aterman
Journal:  Am J Dis Child       Date:  1968-06

3.  Infection of the fetus by Candida in a spontaneous abortion.

Authors:  C Y Ho; K Aterman
Journal:  Am J Obstet Gynecol       Date:  1970-03       Impact factor: 8.661

4.  The teratogenic effects of 5-fluorocytosine in the rat.

Authors:  S Chaube; M L Murphy
Journal:  Cancer Res       Date:  1969-03       Impact factor: 12.701

5.  [Oral antimycotic agent, 5-fluorocytosine].

Authors:  H J Scholer
Journal:  Mykosen       Date:  1970-04-01

6.  Candida albicans infection of the placenta and fetus. Report of a case.

Authors:  N S Albarracin; W S Patterson; M D Haust
Journal:  Obstet Gynecol       Date:  1967-12       Impact factor: 7.661

7.  In vitro studies of 5-fluorocytosine resistance in Candida albicans and Torulopsis glabrata.

Authors:  S Normark; J Schönebeck
Journal:  Antimicrob Agents Chemother       Date:  1972-09       Impact factor: 5.191

  7 in total
  2 in total

1.  Use and safety of antimicrobial agents during pregnancy.

Authors:  A W Chow; P J Jewesson
Journal:  West J Med       Date:  1987-06

2.  Cryptococcosis in pregnancy and the postpartum period: Case series and systematic review with recommendations for management.

Authors:  Katelyn A Pastick; Elizabeth Nalintya; Lillian Tugume; Kenneth Ssebambulidde; Nicole Stephens; Emily E Evans; Jane Frances Ndyetukira; Edwin Nuwagira; Caleb Skipper; Conrad Muzoora; David B Meya; Joshua Rhein; David R Boulware; Radha Rajasingham
Journal:  Med Mycol       Date:  2020-04-01       Impact factor: 4.076

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.